What is the current valuation of the GCC stem cell-therapy market?

The market valuation was $6.5 Million in 2024. Read More

What is the projected market size for the GCC stem cell-therapy market by 2035?

The projected valuation for 2035 is $25.3 Million. Read More

What is the expected CAGR for the GCC stem cell-therapy market during the forecast period 2025 - 2035?

The expected CAGR is 13.15% during the forecast period. Read More

Which application segments are driving growth in the GCC stem cell-therapy market?

The application segments include Cell Therapy, Tissue Engineering, Regenerative Medicine, and Gene Therapy, with valuations ranging from $1.2 Million to $8.0 Million. Read More

What types of stem cells are most prevalent in the GCC market?

The prevalent types include Adult Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells, and Embryonic Stem Cells, with valuations from $0.65 Million to $10.06 Million. Read More

What are the primary sources of stem cells in the GCC market?

The primary sources include Bone Marrow, Cord Blood, Adipose Tissue, and Peripheral Blood, with valuations between $1.3 Million and $8.0 Million. Read More

Who are the key players in the GCC stem cell-therapy market?

Key players include Mesoblast, Athersys, Osiris Therapeutics, Cynata Therapeutics, and Kite Pharma. Read More

What end-user segments are contributing to the GCC stem cell-therapy market?

End-user segments include Hospitals, Research Institutions, Pharmaceutical Companies, and Biotechnology Companies, with valuations from $1.2 Million to $10.2 Million. Read More

How does the growth of the GCC stem cell-therapy market compare to other regions?

While specific regional comparisons are not provided, the GCC market is expected to grow significantly, indicating a robust development trajectory. Read More

What factors are likely to influence the growth of the GCC stem cell-therapy market?

Factors include advancements in technology, increasing investments from key players, and rising demand for innovative therapies. Read More

GCC Stem Cell Therapy Market

ID: MRFR/Pharma/51406-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

GCC Stem Cell Therapy Market Research Report: Size, Share, Trend Analysis By Applications (Orthopedic, Cardiovascular, Neurological, Dermatological, Dental), By Types of Stem Cells (Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells), By Therapeutic Area (Regenerative Medicine, Cancer Treatment, Autoimmune Diseases, Genetic Disorders), and By Procedure Type (Surgical Procedures, Non-surgical Procedures) - Growth Outlook & Industry Forecast 2025 To 2035

GCC Stem Cell Therapy Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Industrial Automation & Equipment, BY Application (USD Million)
  1. 4.1.1 Cell Therapy
  2. 4.1.2 Tissue Engineering
  3. 4.1.3 Regenerative Medicine
  4. 4.1.4 Gene Therapy
2. 4.2 Industrial Automation & Equipment, BY Type of Stem Cells (USD Million)
  1. 4.2.1 Embryonic Stem Cells
  2. 4.2.2 Adult Stem Cells
  3. 4.2.3 Induced Pluripotent Stem Cells
  4. 4.2.4 Mesenchymal Stem Cells
3. 4.3 Industrial Automation & Equipment, BY Source of Stem Cells (USD Million)
  1. 4.3.1 Bone Marrow
  2. 4.3.2 Cord Blood
  3. 4.3.3 Adipose Tissue
  4. 4.3.4 Peripheral Blood
4. 4.4 Industrial Automation & Equipment, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Research Institutions
  3. 4.4.3 Pharmaceutical Companies
  4. 4.4.4 Biotechnology Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Mesoblast (AU)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Athersys (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Osiris Therapeutics (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Cynata Therapeutics (AU)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 StemCells Inc. (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Regen BioPharma (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Tigenix (BE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Kite Pharma (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Vericel Corporation (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY APPLICATION
3. 6.3 GCC MARKET ANALYSIS BY TYPE OF STEM CELLS
4. 6.4 GCC MARKET ANALYSIS BY SOURCE OF STEM CELLS
5. 6.5 GCC MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
9. 6.9 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
10. 6.10 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
11. 6.11 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
12. 6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 (% SHARE)
13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE OF STEM CELLS, 2024 (% SHARE)
15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE OF STEM CELLS, 2024 TO 2035 (USD Million)
16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SOURCE OF STEM CELLS, 2024 (% SHARE)
17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SOURCE OF STEM CELLS, 2024 TO 2035 (USD Million)
18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 (% SHARE)
19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE OF STEM CELLS, 2025-2035 (USD Million)
  3. 7.2.3 BY SOURCE OF STEM CELLS, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Application (USD Million, 2025-2035)

Cell Therapy
Tissue Engineering
Regenerative Medicine
Gene Therapy

Industrial Automation & Equipment By Type of Stem Cells (USD Million, 2025-2035)

Embryonic Stem Cells
Adult Stem Cells
Induced Pluripotent Stem Cells
Mesenchymal Stem Cells

Industrial Automation & Equipment By Source of Stem Cells (USD Million, 2025-2035)

Bone Marrow
Cord Blood
Adipose Tissue
Peripheral Blood

Industrial Automation & Equipment By End User (USD Million, 2025-2035)

Hospitals
Research Institutions
Pharmaceutical Companies
Biotechnology Companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”